Psychiatry · Kingwood, TX
NPI
1902952112
Since 2007
Specialty
Psychiatry
Code 2084P0800X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
19701 Kingwood Dr, Bldg 3
Kingwood, TX, 77339
Phone (281) 358-5701
Groups this clinician bills Medicare through
Medicare paid, 2024
$44K
588 services
Medicare patients, 2024
67
Average age 58
Drug cost, 2024
$163K
2,218 prescriptions
Company payments, 2025
$475
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Athi P Venkatesh was code 99232 (hospital e&m - subsequent), 241 times for 33 patients. In total Athi P Venkatesh billed 588 services in 11 codes, and Medicare paid $44K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-05-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 241 | 33 | $62.01 | $15K |
| 99233 Hospital E&M - Subsequent | Facility | 108 | 31 | $90.49 | $9,773 |
| 99214 Office E&M - Established | Office | 67 | 26 | $59.58 | $3,992 |
| 90870 Treatment - Miscellaneous | Facility | 51 | 14 | $79.97 | $4,078 |
| 99223 Hospital E&M - Initial | Facility | 37 | 32 | $127.88 | $4,732 |
| 99238 Hospital Discharge Management | Facility | 37 | 32 | $64.39 | $2,383 |
By year: 2022 $43K for 574 services; 2023 $63K for 814 services; 2024 $44K for 588 services.
Medicare prescription drug claims, 2024
In 2024, the drug Athi P Venkatesh prescribed most often to Medicare patients was Dextroamphetamine-Amphetamine (Dextroamphetamine/Amphetamine), with 289 prescriptions and refills. In total Athi P Venkatesh wrote 2,218 Medicare prescriptions that cost $163K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 289 | 333 | 44 | $9,278 |
| Alprazolam Generic | 108 | 109 | 24 | $715 |
| Lisdexamfetamine Dimesylate Generic | 84 | 106 | 21 | $20K |
| Fluoxetine Hcl Generic | 76 | 84 | 20 | $675 |
| Lorazepam Generic | 69 | 69 | 20 | $296 |
| Methylphenidate Hcl Generic | 66 | 68 | 14 | $1,757 |
| Mirtazapine Generic | 65 | 71 | 27 | $371 |
| Trazodone Hcl Generic | 64 | 70 | 25 | $323 |
| Olanzapine Generic | 64 | 64 | 19 | $683 |
| Aripiprazole Generic | 63 | 69 | 19 | $1,963 |
| Lamotrigine Generic | 61 | 73 | 21 | $460 |
| Zolpidem Tartrate Generic | 61 | 63 | 29 | $329 |
| Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl | 60 | 60 | Under 11 | $9,869 |
| Sertraline Hcl Generic | 56 | 58 | 18 | $248 |
| Quetiapine Fumarate Generic | 56 | 58 | 37 | $473 |
Brand drugs: 89 claims; generic drugs: 2,129 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Athi P Venkatesh $475 ($475 in general payments such as food, travel and fees) from 9 companies. The largest payer was Teva Pharmaceuticals USA, Inc. with $146.
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. TEVA | 3 | $146 |
| Alkermes, Inc. ALKS | 1 | $129 |
| Axsome Therapeutics, Inc. AXSM | 2 | $45.36 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $41.64 |
| Abbvie Inc. ABBV | 1 | $34.96 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $23.66 |
| Janssen Pharmaceuticals, Inc JNJ | 1 | $19.97 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 1 | $19.48 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 1 | $15.14 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.